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Abstract
Cyclic-di-GMP, a common bacterial second messenger, has been thought to help develop
virulence and biofilms in bacteria, most specifically in Salmonella Typhimurium. By being able
to dysregulate cyclic-di-GMP production, virulence may be better combatted. STM1987, an Larginine-responsive diguanylate cyclase with a periplasmic sensory domain, dimerizes and
generates the bacterial second messenger cyclic-di-GMP in response to the amino acid Larginine in a pathway that also requires the periplasmic L-arginine-binding protein ArtI. Their
biochemical responses to L-arginine and when they dimerize could help clarify this pathway, so I
sought to develop a periplasmic dimerization sensor to better monitor these biochemical
interactions. Similar to STM1987, the ToxR transcriptional regulator from Vibrio cholera is also
activated by dimerization. By switching out the periplasmic domain of ToxR for the periplasmic
regions of interest, I can better evaluate the cyclic-di-GMP response to L-arginine. This research
aims to find the specific responses in this pathway to be able to use this in combatting bacterial
virulence. I was able to successfully show that the STM1987 periplasmic domain dimerizes in
response to L-arginine, providing an important insight into this signaling pathway.
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Introduction
Salmonella Typhimurium
Salmonella Typhimurium is a Gram negative, facultative anaerobic bacillus (Salmonella Medical Microbiology - NCBI Bookshelf, n.d.). Existing around the world, S. Typhimurium is a
food borne pathogen that causes Salmonellosis and produces a range of symptoms from common
gastroenteritis to enteric fevers. While most healthy people will recover without treatment, the
infection can spread beyond the intestines, causing enteric fevers that are life-threatening
(Salmonella Infection - Symptoms and Causes - Mayo Clinic, n.d.). In addition to problems
caused by curable Salmonella infections, S. Typhimurium has increasingly become resistant to
many antibiotics including amoxicillin and chloramphenicol, amongst others (Umair & Siddiqui,
2020). One of the mechanisms which assists S. Typhimurium in antibiotic resistance is by
invading and surviving within the host’s own cells.
To successfully invade and survive within host cells, S. Typhimurium must adhere to,
invade, survive, and proliferate in these host cells. Macrophage infection by S. Typhimurium
primarily is driven by the phagocytosis process that is employed to prevent systemic infection in
most cases. In epithelial cells, this invasion process involves bacterial secretory system proteins.
After either of these invasions, S. Typhimurium can either be killed by the cell, or proliferate
within the cell (Gog et al., 2012). One mechanism that can assist with this survival mechanism
and to promote virulence in mice is low levels of c-di-GMP concentrations after phagocytosis by
macrophages (Petersen et al., 2019). To better understand if this is a possibility, a system to
analyze these interactions may be useful.

Cyclic-di-GMP
Biofilms and Motility
Bacterial signaling and behavior is facilitated by first and second messengers, where
extracellular first messengers regulate levels of cytoplasmic second messengers to carry a signal
to effector proteins (Newton et al., 2016). Cyclic-di-GMP (c-di-GMP) is a common second
messenger present in bacteria that coordinates many different aspects of bacterial growth,
signaling, and behavior including motility, virulence, biofilm formation, and cell cycle
progression. Usually, microorganisms are freely suspended, but biofilms cause these
microorganisms to aggregate and be enclosed by a material primarily composed of
polysaccharides (Donlan, 2002). C-di-GMP has also been shown to have an effect on bacterial
motility, which is critical in bacterial virulence (Sun et al., 2018). Whereas high levels of c-diGMP have been shown to increase the incidence of biofilm formation, low levels of c-di-GMP
have been shown to increase motility.

Diguanylate Cyclases and Phosphodiesterases
Synthesis and degradation of c-di-GMP is controlled by diguanylate cyclases (DGCs) and
c-di-GMP-specific phosphodiesterases (PDEs) respectively (Jenal et al., 2017). DCGs encode
GGDEF domains to combine two molecules of GTP to produce one molecule of c-di-GMP,
while PDEs encode either EAL or HD-GYP domains to hydrolyze c-di-GMP to a linear pGpG to
reverse the process (Hengge, 2016). There are usually multiple GGDEF, EAL, and HD-GYP
domains present in bacterial genomes, suggesting that the regulation of c-di-GMP is highly
complex and dependent on many factors (Sisti et al., 2013). These DGCs and PDEs typically
contain sensory domains that induce dimerization of the respective protein, activating its

enzymatic ability. This then links c-di-GMP to the sensing of specific environmental cues,
affecting the appropriate alteration in bacterial physiology and gene expression.

Bacterial Sensing Through Periplasmic Domains
There are several ways that bacteria can sample the environment, communicate with each
other, and then elicit the appropriate responses in order to survive. Periplasmic binding proteins
are receptors in the periplasm of bacteria that detect changes and mediate various processes such
as transport, chemotaxis, quorum sensing, biofilm formation, and motility. Because these
periplasmic proteins can affect biofilm formation and motility, they can play a role in antibiotic
resistance (Borrok et al., 2009). Two-component systems are another key system in bacterial
signal transduction. Typically comprised of a histidine kinase for sensing external input signals
and a response regulator to communicate the appropriate change in the physiology of the
bacteria, several studies have shown that two-component systems are crucial for expression of
virulence factors, viability, and growth (Tiwari et al., 2017). When the histidine kinase is
activated by a signal, the kinase activity is then activated, and autophosphorylation of itself then
occurs. This phosphorylated kinase can then transfer that phosphate to the response regulator,
stimulating a down-stream response.

L-Arginine Sensing in a Cyclic-di-GMP Pathway
Many organisms contain several c-di-GMP modulating enzymes with periplasmic
sensory domains, but there are few that have been linked to particular signals that modulate their
activity. As shown by Mills et. al., some of these signals include L-arginine, glucose, salicylic
acid, and N-acetyl-D-glucosamine. Of these, N-acetyl-D-glucosamine, glucose, and L-arginine

were shown to increase c-di-GMP, while salicylic acid was shown to decrease c-di-GMP. Larginine was shown to produce the largest change in c-di-GMP and at the lowest concentration
of all the compounds tested (Mills et al., 2015). This study also showed that this response is
specific to L-arginine.
Salmonella Typhimurium’s genome contains 17 cyclic-di-GMP metabolizing enzymes,
including the diguanylate cyclase STM1987. This previous study identified an S. Typhimurium
c-d-GMP pathway that responded to L-arginine by increasing c-di-GMP concentrations through
activation of the DGC STM1987. This pathway also required an L-arginine sensing periplasmic
binding protein, ArtI, but the exact mechanism of ArtI’s interaction with STM1987 is unknown.
ArtI may induce dimerization of STM1987 to increase the concentration of free c-di-GMP (Mills
et al., 2015). Figuring out the exact mechanism of this process is crucial to better understanding
this regulatory pathway, and hopefully to find a way to decrease incidence of bacterial virulence.

ToxR
Role in Vibrio cholerae
Vibrio cholerae, the bacteria that causes cholera, has multiple mechanisms for its
pathogenesis. Both the tcp operon, which codes for the toxin coregulated pilus, and the ctx
operon, which codes for cholera enterotoxin, must be expressed. This process is regulated by two
membrane proteins, ToxR and ToxS (Bina et al., 2003). ToxR is a transmembrane DNA binding
protein that positively controls transcription of genes for the cholera toxin and contributes to its
pathogenicity (Parsot & Mekalanos, 1990). For this system to work, the transmembrane receptor
ToxS must detect an appropriate signal within the periplasm, induce dimerization of ToxR, and

stimulate expression from ToxR-regulated promoters. The ctx promoter then activates to allow
Vibrio cholerae to adapt appropriately to its environment.

Use as a Sensor
Because ToxR in Vibrio cholerae dimerizes to produce an appropriate response, similar
to DGCs and PDEs, this mechanism is very adaptable with the proteins of interest. The ToxR
system is well understood and can be used as a model for c-di-GMP enzyme dimerization. By
replacing the periplasmic fragment of ToxR for the periplasmic regions of interest that are
related to c-di-GMP production, we can detect dimerization-induced transcriptional expression
of different reporters to measure mCherry for fluorescence, CamR for chloramphenicol
resistance, and LacZ(Y) for orange and blue colorimetric. This system and figuring out the
pathways is crucial because we can use Salmonella Typhimurium as a model organism, and once
we figure this pathway out, any periplasmic signaling protein can be put in place and expanded
to other bacteria and other signals.

Plans
After finding appropriate conditions for optimal growth, this system can then be
translated for use in other bacteria and signaling proteins, which is the long-term goal. For this
experiment specifically, once the optimal mCherry reporter conditions have been found, we can
then transition to using chloramphenicol resistance and LacZ(Y) as reporters. But first, I sought
to test my hypothesis that L-arginine results in dimerization of the STM1987 periplasmic
domain, and that this dimerization could be detected through our ToxR Dimerization Reporter
system.

Methods and Materials
Bacterial Culture Conditions
Standard growth of bacteria was conducted in LB broth at 37°C shaking at 250rpm.
Bacteria for L-arginine testing was grown for about 24 hours at 37°C, shaking in 2mL of
minimal media. This minimal media consists of .5X M63 salts (21 mM K2HPO4, 11mM
KH2PO4, 3.8 mM (NH4)2SO4, ~3.8 mM KOH) (Mills et al., 2015), 1X essential MEM amino
acids, 1X nonessential MEM amino acids, 0.23% glycerol, 1mM MgCl2, 10uM FeSO4, 1 mM
NaCl, and autoclaved MilliQ water. When necessary, 100μg/mL ampicillin, 50μg/ml kanamycin,
or 34μg/ml chloramphenicol was included for strain selection. The various bacterial strains used
are shown in Table 1.
Name
Mach1
EM012
O395
MG1655
DMST001
DMST002
DMST003
DMST004
DMST005
JHST001
JHST002
JHST003
JHST004
JHST005
Table 1: Bacterial Strains Used.

Strain
E. coli str. W ∆recA1398 endA1 fhuA
Φ80∆(lac)M15 ∆(lac)X74 hsdR(rK–mK+)
Salmonella enterica serovar Typhimurium 14028
Vibrio cholerae
Escherichia coli
14028, pEP392
14028, pEP421
14028, pEP413
14028, pEP404
14028, pEP414
14028, pEP455
14028, pEP451
14028, pEP449
14028, pEP450
14028, pEP416

Source
Invitrogen
ATCC
ATCC
ATCC
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

Cloning
The method used to create these plasmids with our proteins of interest was a method
called Gibson cloning; this method requires three enzymatic activities, including a 5’

exonuclease to generate long overhangs, a polymerase to fill in the gaps of the annealed single
stranded regions, and a DNA ligase to seal the nicks of the annealed and gaps that were filled in
(Gibson et al., 2009). The plasmids used are shown in Table 2.
Name

Plasmid

pUC19
pMMBA
pEP392

pUC19
pMMB67EH
pUC-TDR4emptymCherry
pUC-TDR41987mCherry

pEP421

pEP413

pUC-TDR43615mCherry

pEP404

pUC-TDR4ArtImCherry
pUC-TDR4PhoQmCherry

pEP414

pEP416
pEP455
pEP451
pEP449
pEP450

CS944

pMMBA-TDR4empty-mC
pMMBA-TDR41987-mC
pMMBA-TDR43615-mCherry
pMMBA-TDR4ArtI-mCherry
pMMBA-TDR4PhoQ-mCherry
mCherry donor
pKD3

Ab
resistance
Amp
Amp
Amp

Description

New England Biolabs
(Fürste et al., 1986)
TDR4 construct containing the empty
mCherry reporter
Amp
TDR4 construct containing the 1987
periplasmic fragment and the mCherry
reporter
Amp
TDR4 construct containing the 3615
periplasmic fragment and the mCherry
reporter
Amp
TDR4 construct containing the ArtI
periplasmic gene and the mCherry reporter
Amp
TDR4 construct containing the PhoQ
periplasmic fragment and the mCherry
reporter
Amp
pMMBA containing empty TDR4 construct
with mC reporter
Amp
TDR4 construct in pMMBA with mC reporter
and 1987 periplasmic domain
Amp
TDR4 construct in pMMBA with mCherry
reporter and 3615 periplasmic domain
Amp
TDR4 construct in pMMBA with mCherry
reporter and ArtI periplasmic domain
Amp
TDR4 construct in pMMBA with mCherry
reporter and PhoQ periplasmic domain
(Shaner et al., 2004)
Cam/Amp Template vector for frt-Cam-frt lambda red
marker, in R6kγ backbone (Datsenko &
Wanner, 2000)

Table 2: Plasmids Used in this Study

Primer Name
rrnB Term
Gfwd

Sequence
5’-GGCTGTTTTGGCGGATGAGAGAAG-3’

pMMB GRvs1
pMMB GFwd1
pMMB GRvs2
pMMB GFwd2
Ptac MCS
GRvs

5’-GCCGACCTGTATGAACGC-3’
5’-CATGCCGGAGTTCGTCG-3’
5’-CATCCGCTGGCAGTCCTA-3’
5’-GCAGCTCGGTACTGGTC-3’
5’-CAATTTCACACAGGAAACAGAATTCG-3’

TDR4 PtacToxR

5’-ATAACAATTTCACACAGGAAACAGAATTCG
ATGTTCGGATTAGGACACAACTCAAAAGAG-3’

TDR4
rrnBTermPctxA

5’-GAAAATCTTCTCTCATCCGCCAAAACAGCC
TACCGTTACCGGATTTCAATCACTTTGTGG-3’

Cam GFwd

5’ - TATTTTTCTGTTAAACAAAGGGAGCATTAT
ATGGAGAAAAAAATCACTGGATATACCACC - 3’
5’- GGATGGCCTTTTTGCGTTTCTACAAACTCT
TCATCGCAGTACTGTTGTATTCATTAAGCA - 3'
5’ - TATTTTTCTGTTAAACAAAGGGAGCATTAT
ATGGTGAGCAAGGGCGAGGAGGATAACATG - 3’
5’ - GGATGGCCTTTTTGCGTTTCTACAAACTCT
TTACTTGTACAGCTCGTCCATGCCGCCGGT - 3’
5’ - TATTTTTCTGTTAAACAAAGGGAGCATTAT
ATGACCATGATTACGGATTCACTGGCCGTC - 3’
5’ - GGATGGCCTTTTTGCGTTTCTACAAACTCT
TTAAGCGACTTCATTCACCTGACGACGCAG - 3’
5’ - GGATGGCCTTTTTGCGTTTCTACAAACTCT
GTTATTATTATTTTTGACACCAGACCAACT - 3’

Cam GRvs
mCherry GFwd
mCherry GRvs
LacZY GFwd
LacZY GRvs
LacZ GRvs

rrnB Term
5’-GGCTGTTTTGGCGGATGAGAGAAG-3’
Gfwd (Gateway
Fragment)
pMMB2GRvs1
(Gateway
Fragment)

5’-CAACAGCGAGGCAGCATG-3’

Use
Gibson primer within
rrnB terminator to
clone into MCS with
rrnB terminator
Primers in backbone
to amplify pMMB
fragments for Gibson
cloning
Primer to amplify
through the Ptac
promoter to clone
into Ptac MCS
Primer to amplify
TDR4 at ToxR end
for insertion into Ptac
MCS
Primer to amplify
TDR4 at PctxA end
for insertion into
rrnB MCS (Ptac)
Primers to insert
Cam marker into
reporter plasmid
Primers to insert
mCherry into
reporter plasmid
Primers to insert
LacZY into reporter
plasmid
Reverse primer to
insert LacZ into
reporter plasmid
Gibson primer within
rrnB terminator to
clone into MCS with
rrnB terminator
Primers to improve
efficiency within

pMMB2GFwd1
(Gateway
Fragment)
pMMB2GRvs2
(Gateway
Fragment)
pMMB2GFwd2
(Gateway
Fragment)
Ptac MCS
GRvs (Gateway
Fragment)

5’-GCATGGAGCCGAAAA-3’

pMMB backbone for
Gibson reactions

5’-CATCCGCTGGCAGTCCTA-3’

5’-GCAGCTCGGTACTGGTC-3’

5’-CAATTTCACACAGGAAACAGAATTCG-3’

Primer to amplify
through the Ptac
promoter to clone
into Ptac MCS

Table 3: Primers Used in this Study

Gibson PCR cloning fragments were generated using the primers found in Table 3,
Phusion DNA Polymerase (ThermoFisher), dNTPs, buffer, and DNA template. Coding sequence
for the ToxR DNA binding/transmembrane domain and the ctxA promoter were cloned from the
V. cholerae O395 genome. The transcriptional terminator was cloned from the pBAD24 vector,
while the mCherry fragment was cloned from a lab fluorescent expression vector. We also
generated a CamR reporter using the pKD3 (Datsenko & Wanner, 2000)plasmid as a template,
and a LacZ(Y) reporter using the E. coli MG1655 genomic DNA as a template, but we were able
to achieve our aims without using these reporters yet. These components were first Gibson
cloned into the high copy pUC vector to generate a ToxR-empty control. Periplasmic regions of
interest were then cloned from the S. Typhimurium 14028 genome into this vector to generate Cterminal fusions to the ToxR fragment. The periplasmic domain of STM1987 and the entire ArtI
periplasmic binding protein without secretion signal peptide were cloned to test their
dimerization in response to L-arginine. As controls, the periplasmic domains from another c-diGMP metabolizing enzyme (STM3615) and the histidine kinase PhoQ (Dubey et al., 2016) were
also cloned into the ToxR vector. Subsequent constructs were transferred to the low copy

pMMBA vector. Both pUC and pMMBA contain an ampicillin resistance gene to ensure that the
plasmid was successfully inserted.

Conjugation and Phage Transduction
To get these plasmids into the Salmonella, two methods were used: conjugation/phage
transduction and electroporation. The conjugation/phage transduction protocol began by
growing up 2ml overnight cultures with ampicillin (pUC or pMMBA), an antibiotic-resistant S.
Typhimurium strain (a previously constructed ΔsseG::Cam strain was used), and the pRK2013
conjugation helper strain. The next day, these were washed twice in LB without antibiotics by
centrifuging and resuspending. Strains were then combined in the triparental mating mixture
(helper/donor/recipient), centrifuged, the pellet was resuspended in 50μl, and it was plated to a
dried LB plate to allow conjugation to proceed. After an overnight incubation at 37°C, these
conjugation spots were struck to LB agar plates containing ampicillin and chloramphenicol to
select for S. Typhimurium bacteria that had acquired the pUC or pMMBA vector.
To transfer the bacteria from the ΔsseG::Cam to wild type S. Typhimurium, a mutant
variant of the P22 phage that indiscriminately packages random DNA was used to transduce the
vector (Casjens et al., 1988). Phage transduction began with a 2mL LB overnight cultures with
ampicillin of the donor ΔsseG::Cam with vector (pMMBA or pUC). The next day, 1mL of LB
and 1.5ul of a bacteriophage (P22-HTInt) grown from the wild-type Salmonella was combined,
and then 500ul of the overnight donor vector culture was added for a final phage concentration of
1:1000. This was then incubated at 37°C in the shaker overnight. At the same time, a 2mL LB
culture of the recipient wild type Salmonella strain was started. The next day, 1mL of the phage
culture was centrifuged at maximum speed to pellet the bacteria. 900ul of the supernatant was

removed and 100ul of chloroform was added to the supernatant, vortexed well, and allowed to sit
for 5 minutes to kill any remaining bacteria. The sample was vortexed again and then centrifuged
to separate the layers. The supernatant produced from this step is now the bacteriophage that was
to be used.
To 1mL of LB, 2ul of the bacteriophage was added for a final phage concentration of
1:1000 and then mixed. 150ul each of the recipient Salmonella strain was added two separate
tubes; to the negative control tube, 150ul of LB was added, and to the experimental tube, 150ul
of the diluted bacteriophage was added. All tubes were incubated at 37°C and shaken for 1-2
hours, then each of these was plated to LB agar plates containing ampicillin. As long as the
control plates did not have colonies present, colonies from the transduction plates were struck
out onto green phage plates to cure the culture of phage (Schmieger, 1972). From these same
plates, any single, white colonies were picked and struck out onto another phage plate to ensure
no more phage is present the next day. If there are single, white colonies on these plates, they
were picked the next day and grown in LB with ampicillin. This was grown overnight, and a
PCR was performed on the overnight culture the next day to confirm presence of the vector. A
glycerol stock was frozen down for future use.

Electroporation
As an alternative method to get the prepared plasmids into the wild-type Salmonella,
overnight cultures of Mach1 E. coli containing the ToxR Dimerization Reporters were started in
LB and ampicillin. A second culture of recipient wild type Salmonella was started in 2ml of LB.
The next day, in new LB, a 1:1000 dilution of the recipient Salmonella strain was started, and
this culture was grown for about 2 hours, or until 1 optical density (OD600). ToxR Dimerization

Reporter plasmids were then purified from Mach1 E. coli using a miniprep kit (IBI Scientific).
For every plasmid that needed to be transferred to the bacteria, 1.5 mL of the culture was
centrifuged, the supernatant was decanted, and the pellet was washed and resuspended in 750ul
of DNase free water. There were 3 total washes, and the supernatant was decanted again after the
third wash. The bacteria were resuspended in at least 550ul of DNase free water, adding another
100ul for every sample above 5. To 97ul of electrically competent cells, 3ul of the purified
plasmid was added. This was transferred to an electroporation cuvette, and an automated
protocol on the electroporator was selected to shock the cells and get the plasmid in the cells.
500ul of SOC was added to the cuvette, mixed, transferred to a bigger tube, and the bacteria was
grown for 1-2 hours. This was repeated for every plasmid needed. After their growth, these
reactions were plated to LB agar plates containing ampicillin, single colonies were grown
overnight, and these cultures were PCR tested for presence of the vector. As each sample was
completed, they were frozen down in glycerol for later use.

mCherry ToxR Dimerization Reporter Assay
2mL overnight cultures of empty mCherry (mC), ArtI-mC, 1987-mC, 3615-mC, and
PhoQ-mC were started and grown in M63 minimal media at 37°C. The next day, M63 without
amino acids, which were replaced with water, was made, and 4 different testing conditions per
strain were made. Every strain contains ampicillin, but the four different conditions were with
IPTG and with L-arginine, with IPTG and without L-arginine, without IPTG and with Larginine, and without IPTG and without L-arginine. The bacteria were added 1:100, and this was
grown for 2 hours, shaking at 37°C. 200ul of each sample was added to a 96-well plate, and the
mCherry fluorescence was read in the Synergy HTX plate reader (Biotix). Where noted, an

OD600 reading was also taken of the bacterial culture alongside the mCherry fluorescence
readings so that we could normalize to bacterial density.

Statistical Analysis
To evaluate the response of the reporter system, first the arginine effect of each strain
needed to be calculated; this was done by dividing the fluorescence amount of the strain with the
arginine by the fluorescence of the same strain without the arginine. To get the relative effect, the
arginine effect value for each strain was divided by the arginine effect value for the emptymCherry. This was to normalize all the values to the negative control. Once enough data was
gathered using this method, a one-way matched ANOVA test was run to test for statistical
significance.

Results
ToxR Dimerization Reporter Construction
Due to the ToxR system in Vibrio cholerae dimerizing in a similar way to predicted c-diGMP metabolizing enzymes, this system was adapted with my proteins of interest to test whether
STM1987 dimerizes in response to L-arginine. The plasmids of interest, including emptymCherry, 1987-mC, ArtI-mC, 3615-mC, and PhoQ-mC were generated by Gibson cloning
(Figure 1). Then, electroporation, conjugation, and phage transduction were used to move these
plasmids into the bacteria, which was wild-type Salmonella Typhimurium. To test the system
itself, overnight cultures of the bacteria with different plasmids were grown overnight at 37°C
while shaking in minimal media with essential amino acids. The next day, 1 mL of the overnight
cultures was removed, centrifuged, and washed down twice with the same minimal media made

without amino acids. As the amino acid mixture contains L-arginine, this is required to generate
a no-arginine condition. These were resuspended in 1 mL of the media, and the 2-hour cultures
were started at 0.25 OD600 in the same minimal media without amino acids. Each plasmid had
one sample with 20mM L-arginine and without L-arginine. These were again grown at 37°C
while shaking, and then 200ul of each sample was added to a 96-well plate and the fluorescence
was measured using the Synergy HTX plate reader (Biotix).

Figure 1: Plasmid map of the ToxR Dimerization Reporter. Ptac is the IPTG inducible
promoter that controls expression of the ToxR fusion, ToxR DBD is the ToxR DNA binding
domain, TM is the transmembrane region, the peri. domain is the periplasmic region, PctxA is
the ToxR-inducible promoter, and mCherry is the fluorescence reporter.

Testing and Optimization
A large portion of this project was determining the appropriate conditions for growth.
There were many adjustments and testing conditions to determine what would work best. The
first set of tests used low copy pMMBA plasmids, had L-arginine at 100uM, and the IPTG was
added at .5mM. We failed to see any significant results, most likely due to a mixture of
insufficient conditions, so we began to optimize the assay. Among variables tested included
different IPTG concentrations (0.1mM and 0.5mM), adding IPTG to the overnight cultures in
addition to the two-hour cultures, giving strains 3 hours of growth the next day instead of 2

hours, or concentrating the bacteria via centrifugation and resuspension after a 2-hour growth.
After comparing the fluorescence of these strains to a wild type S. Typhimurium strain without
any vector, it was apparent that the low copy pMMBA reporter plasmids were not giving high
enough fluorescence to see significant results.
We then decided to switch strategies and try the high copy pUC reporter vector. This
seemed to work well, and the new protocol was to use pUC because it provides a higher copy
number, and therefore higher fluorescence readings. After being grown overnight in M63 media
with amino acids and ampicillin, the cultures were grown without amino acids for 2 hours with
and without L-arginine the next day. The finalized protocol became to grow up the bacteria with
the pUC plasmids overnight in M63 with amino acids and ampicillin, spin down 1 mL of the
overnight culture the next day, wash twice with M63 media without amino acids, and resuspend
in 1 mL of M63 without amino acids with ampicillin with or without L-arginine. The OD600 was
measured, and all cultures were grown for 2 hours starting at 0.25 OD600, with and without 20
mM of L-arginine, which became our standard protocol.

L-Arginine Induces Dimerization of the STM1987 Periplasmic Domain
To determine how L-arginine influences dimerization of the STM1987 and ArtI
periplasmic components, we conducted the optimized protocol alongside the empty, STM3615,
and PhoQ periplasmic reporters. Once the fluorescence numbers were obtained from the plate
reader, various statistical analyses were conducted. First, the L-arginine effect was calculated by
dividing the fluorescence of each strain with L-arginine by the fluorescence of the sample
without L-arginine. This indicated how much fluorescence change there was in response to the
addition of L-arginine. Then, because we considered there could be non-specific effects of L-

arginine, we normalized to the empty mCherry vector control to remove those effects from
analysis. This gave us the relative arginine effect. (Figure 2). Only the STM1987 periplasmic
domain exhibited a significant response to the addition of L-arginine.
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Figure 2: STM1987-ToxR fusion dimerizes in response to L-arginine. Relative mCherry
expression in percentages. mCherry-empty is not included due to the relative expression being
100%, and all the other data is normalized to that. STM1987 shows statistical significance, with
p<0.05. Statistical analysis completed using a One-Way Matched ANOVA test.

Discussion
The ToxR Dimerization Reporter was created to evaluate the biochemical interactions
involved in the Salmonella and L-arginine system to evaluate if STM1987’s sensory periplasmic

domain will dimerize in response to L-arginine. The ToxR system in Vibrio cholerae dimerizes
in the same way that c-di-GMP metabolizing enzymes are predicted to do, so the ToxR system
was adapted for use in the testing of STM1987 to determine if it does dimerize in response to Larginine.

Figure 3: Model of STM1987-ToxR fusion dimerizing in response to L-arginine, causing
the mCherry reporter to show fluorescence

Using my ToxR Dimerization Reporter, I was able to show that the addition of L-arginine
resulted in dimerization of the ToxR fusion and expression of mCherry (Fig. 3).
This finding supports my hypothesis and opens this system up to future work discovering the
mechanisms of this regulatory pathway. Interestingly, ArtI seems to show an increase in
fluorescence, although results weren’t statistically significant. While we anticipate that ArtI
binds arginine, that does not necessarily mean that it dimerizes in response to it; based on these
results, it is very possible that it does not dimerize in response. This slight upward change could
be due to dimerization response but an instability in the ArtI-ToxR fusion, or could just be
background. Repeating these experiments, or generating an ArtI protein deficient in L-arginine
binding, may help to resolve this question. Both STM3615 and PhoQ periplasmic domains show
very little change in response to L-arginine, consistent with them having no role in the L-arginine

c-di-GMP response. We believe that the fluorescence shown by STM3615 and PhoQ could be
background fluorescence as these strains do not show much difference from the empty-ToxR
mCherry reporter, but further testing is needed to confirm this. While the ToxR Dimerization
Reporter still requires further testing, based on these results it would appear that this system does
work and is selective enough that it will not cause dimerization of everything.

Future Plans
There are several avenues still to explore, both within the STM1987/ArtI/L-arginine
system and expanding the ToxR Dimerization Reporter to further pathways. These experiments
were mostly conducted with pUC plasmids, but pMMBA plasmids can be used as well, as this
optimization proved to be difficult. Further testing can be conducted to differentiate what the
original problem was, and how the fluorescence can reach the readable range. One option may be
that we need to separate the ToxR fusion construct from the mCherry reporter. Placing them on
separate vectors may allow us to better fine tune our results. To better understand the STM1987
dimerization, various concentrations of L-arginine can be tested to determine minimum values
for this system to still work correctly. Different reporters can also be tested; here, only mCherry
was tested, but LacZY, which shows blue and orange colorimetric changes, and CamR, which
shows chloramphenicol resistance, can also be used as different reporters. In addition, we can
also expand the STM1987 dimerization reporter into different mutant strains to determine what
is necessary for this to work properly. For instance, ArtI knockout mutants can be created to see
if ArtI is necessary to dimerize STM1987, as would be hypothesized due to the requirement for
ArtI in L-arginine-induced activation of STM1987 c-di-GMP production. Finally, this system

can also be expanded to other periplasmic domains, as the main goal is for this system to be
adaptable for anything that follows this same process.

Conclusion
Cyclic-di-GMP is a common bacterial second messenger that is thought to regulate
virulence in Salmonella Typhimurium. By discovering the parts of these c-di-GMP pathways and
their biochemical interactions, virulence may be better combatted with the disruption of these
pathways. Additionally, if this pathway works, it can then be adapted to test any bacterial signal
that causes dimerizes in the same way. The experimentation conducted so far has shown that
STM1987, a diguanylate cyclase, does dimerize in response to L-arginine. This was shown with
statistical significance, and because the negative controls used did not show statistical
significance, it can be concluded that this system is selective, and that it does not cause
dimerization of every plasmid that is put into this system; it only dimerizes those that should be
dimerizing in response. As most c-di-GMP modulating enzymes and histidine kinase sensors of
two component systems are thought to activate through dimerization, this provides a wealth of
future opportunities to investigate using this ToxR Dimerization Reporter.
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